• A Chinese family with congenital Dysfibrinogenemia carries a heterozygous missense mutation in FGA: Concerning the genetic abnormality and clinical treatment
• A dysfibrinogenemia leading to resistance to bovine thrombin
• A family study of congenital dysfibrinogenemia caused by a novel mutation in the FGA gene: A case report
• A Family with Congenital Dysfibrinogenemia and Blood Transfusion
• A low-dose therapy of fibrinogen supplement during perioperative period of total knee arthroplasty in an asymptomatic man with congenital dysfibrinogenemia: A case report
• A novel fibrinogen variant in a Chinese pedigree with congenital dysfibrinogenemia caused by FGA P. Arg38Thr mutation: A case report
• A novel heterozygous mutation (gammaIIe367Thr) causes congenital dysfibrinogenemia in a Chinese family
• A novel heterozygous mutation (γIIe367Thr) causes congenital dysfibrinogenemia in a Chinese family
• A novel mutation in exon 2 of FGB caused by c.221G>T ^† substitution, predicting the replacement of the native Arginine at position 74 with a Leucine (p.Arg74Leu ^† ) in a proband from a Kurdish family wi
• A novel mutation in exon 2 of FGB caused by c.221G>T () substitution, predicting the replacement of the native Arginine at position 74 with a Leucine (p.Arg74Leu () ) in a proband from a Kurdish family with dysfibrinogenaemia and familial venous and ar
• A novel mutation in the FGG gene causes hypofibrinogenemia in a Chinese family
• A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family
• Analysis of a family with congenital dysfibrinogenemia caused by an Arg275His mutation in the gamma chain of fibrinogen
• Analysis of a pedigree affected with congenital dysfibrinogenemia due to a novel Gly31Glu mutation of FGA gene
• Analysis of two pedigrees affected with inherited dysfibrinogenemia due to a novel c.1115 T>A variant of the FGB gene
• Analysis of two pedigrees affected with inherited dysfibrinogenemia due to a novel c.1115 T>A variant of the FGB gene
• Anticoagulation is an effective treatment for aortic mural thrombi
• Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen
• c.259A&gt;C in the fibrinogen gene of alpha chain (<em>FGA</em>) is a fibrinogen with thrombotic phenotype
• Can the phenotype of inherited fibrinogen disorders be predicted?
• Clinical and genetic analysis of 8 Chinese pedigrees with inherited dysfibrinogenemia
• Clinical features and genetic defect in six index patients with congenital fibrinogen disorders: Three novel mutations with one common mutation in Taiwan's population
• Clinical Features and Management of Congenital Fibrinogen Deficiencies
• Clinical phenotype and laboratory characteristics of 93 patients with congenital fibrinogen disorders from unrelated 36 families
• Coexisting congenital dysfibrinogenemia with a novel mutation in fibrinogen gamma chain (gamma322 PheIle, Fibrinogen Beijing) and haemophilia B in a family
• Coexisting congenital dysfibrinogenemia with a novel mutation in fibrinogen γ chain (γ322 Phe→Ile, Fibrinogen Beijing) and haemophilia B in a family
• Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia
• Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aalpha and Bbeta chain mutations in two Tunisian families
• Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families
• Congenital dysfibrinogenemia caused by gammaAla327Val mutation: structural abnormality of D region
• Congenital dysfibrinogenemia caused by γAla327Val mutation: structural abnormality of D region
• Congenital dysfibrinogenemia in a Japanese family with fibrinogen Naples (BbetaAla68Thr) manifesting as superior sagittal sinus thrombosis
• Congenital dysfibrinogenemia in a Japanese family with fibrinogen Naples (BβAla68Thr) manifesting as superior sagittal sinus thrombosis
• Congenital dysfibrinogenemia in major surgery: A description of four cases and review of the literature
• Diagnosis of congenital fibrinogen disorders
• Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias
• Dusart Syndrome in a Scandinavian family characterized by arterial and venous thrombosis at young age
• Dysfibrinogenemia in a patient undergoing artificial abortion after misdiagnosis and review of the literature
• Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens
• Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding
• Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management
• Exome Sequencing and Clot Lysis Experiments Demonstrate the R458C Mutation of the Alpha Chain of Fibrinogen to be Associated with Impaired Fibrinolysis in a Family with Thrombophilia
• Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment
• Fibrinogen BOE II: dysfibrinogenemia with bleeding and defective thrombin binding
• Fibrinogen BOE II: Intracerebral hemorrhage associated with a novel compound mutation in a Chinese family with dysfibrinogenemia
• Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)--&gt;stop (TAA)
• Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization
• Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis
• Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg--&gt;Cys and Aalpha 16 Arg--&gt;His dysfibrinogenemia
• Fibrinogen Novy Jicin and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia
• Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release
• Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia
• Fibrinogen Sumperk II: dysfibrinogenemia in an individual with two coding mutations
• Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg--&gt;His (CGT--&gt;CAT) with aberrant fibrinopeptide A release
• Functional analysis for dysfibrinogenemias, Toyama and Adachi, which have a mutation of Aalpha16Arg-->His (CGT-->CAT) with aberrant fibrinopeptide A release
• Functional analysis of heterozygous plasma dysfibrinogens derived from two families of gammaArg275Cys and three families of gammaArg275His, and haplotype analysis for these families
• Functional study of abnormal fibrinogen caused by Arg275His mutation in fibrinogen γ chain
• Genetic Analysis of A Case of Congenital Dysfibrinogenemia Caused by Arg16His Mutation in Exon 2 of FGA
• Genetic analysis of a Chinese pedigree affected with Congenital dysfibrinogenemia due to variant of FGG gene
• Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation
• Guideline for diagnosis and management of congenital dysfibrinogenemia
• Haematologic disorders and cerebral venous thrombosis
• Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis
• Hiding in plain sight: Diagnosing congenital dysfibrinogenemia in a child presenting with acute myeloid leukemia
• Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications
• Identification of a dysfibrinogenemia of gammaR275C (Fibrinogen Fukushima)
• In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I
• Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group
• Inherited dysfibrinogenemia caused by Arg16His mutation in alpha chain of fibrinogen.
• Inherited dysfibrinogenemia caused by Arg275His in the beta chain of fibrinogen
• Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects
• Investigation of pathological haemorrhage in Maine Coon cats
• Laboratory diagnosis of dysfibrinogenemia
• Laboratory diagnosis of thrombophilic states: where do we stand?
• Management of congenital dysfibrinogenemia in pregnancy: A challenging patient case
• Management of dysfibrinogenemia in pregnancy: A case report
• Misdiagnosis of a patient with congenital dysfibrinogenemia: A case report and literature review
• Molecular basis of fibrinogen deficiency
• Molecular genetics of quantitative fibrinogen disorders
• Mutation analysis of a FGG gene causing hereditary abnormal fibrinogen
• Mutations in inherited fibrinogen disorders correlated with clinical features in the Chinese population
• Novel fibrinogen mutations (Aα17Gly→Cys and Aα381Ser→Phe) occurring with a 312Thr→Ala polymorphism: allelic phase assigned by direct mass measurement
• Occurrence of thrombosis in rare bleeding disorders
• Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis
• Pathogenesis study of inherited dysfibrinogenemia
• Pedigree Analysis and Diagnosis of Congenital Dysfibrinogenemia: A Case Report
• Perioperative management of pregnant women combined with congenital fibrinogen deficiency: four cases report and literature review
• Phenotype and genotype analyses of two pedigrees with inherited fibrinogen deficiency
• Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders
• Role of newly developed technology in blood coagulation disorders
• Severe Wound Healing Impairment in a Patient with Dysfibrinogenaemia
• Spinal anaesthesia and dysfibrinogenaemia
• Structural changes in the fibrin network of a pretoria family with dysfibrinogenemia: a scanning electron microscopical study
• Successful living-related kidney transplantation in a boy with inherited dysfibrinogenemia
• The <em>FGG</em> c.952G&gt;A variant causes congenital dysfibrinogenemia characterized by recurrent cerebral infarction: a case report
• The dilemma of inherited dysfibrinogenemia during pregnancy
• The FGG c.952G>A variant causes congenital dysfibrinogenemia characterized by recurrent cerebral infarction: a case report
• Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His
• Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy
• Two symptomatic cases of dysfibrinogenemia in China: one with gamma-chain Arg275Cys mutation and another without detectable mutation in fibrinogen genes